Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

CHRISTUS Santa Rosa Hospital - Westover Hills and Dr. Robert Farber Bring Innovation to Local Patients

First surgeries in the nation performed with San Antonio-based Nvision Biomedical Technologies Trigon® Osteotomy Wedge System.


News provided by

Nvision Biomedical Technologies

May 06, 2021, 16:00 ET

Share this article

Share toX

Share this article

Share toX

The Trigon® Stand – Alone Wedge Fixation System with screws available in Evans and Cotton osteotomies with PEEK-Optima® HA Enhanced material.
The Trigon® Stand – Alone Wedge Fixation System with screws available in Evans and Cotton osteotomies with PEEK-Optima® HA Enhanced material.

SAN ANTONIO, May 6, 2021 /PRNewswire-PRWeb/ -- Robert Farber, DPM of San Antonio Podiatry Associates, performed the first two surgeries utilizing the Trigon® Osteotomy Wedge system developed by San Antonio-based Nvision Biomedical Technologies at the CHRISTUS Santa Rosa Hospital – Westover Hills. The Trigon system provides an innovative use of PEEK-OPTIMA® HA Enhanced, which promotes multi-directional bone healing, improved fixation and enabled unique device identification required by the FDA.

The Trigon Osteotomy Wedge is the first osteotomy wedge system made from PEEK-OPTIMA® HA Enhanced, a polymer from Invibio Biomaterial Solutions. The Trigon® Stand-Alone Osteotomy Wedge Fixation System has osteoconductive properties that promote multi-directional bone healing and improved fixation without introducing material-related bio-incompatibility reactions. The Trigon system enables a standard surgical technique that allows direct and exact placement of implant and screws without additional plating. Additionally, the Trigon system utilizes Structural Encoding® to enable the Unique Device Identification (UDI) required by the FDA.

It is an ideal situation when you have the opportunity to work with an innovative company locally with products that are more intuitive to utilize in surgery with the patient in mind,

Post this

"It is always our goal to deliver high quality health care that improves the health of our community. Being the host of these groundbreaking orthopaedic surgeries is a stellar example of that commitment," said Patricia Burns, President, CHRISTUS Santa Rosa Hospital – Westover Hills. "Our hospital is proud to partner with manufacturers like Nvision that develop technology resulting in better patient outcomes."

"It is an ideal situation when you have the opportunity to work with an innovative company locally with products that are more intuitive to utilize in surgery with the patient in mind," said Dr. Farber. "Nvision is bringing innovation to the San Antonio community through its devices and an in-house cadaver lab, which helps test devices, make adjustments, and accelerate the benefit to patients."

In the weeks since the initial surgeries, surgeons across the country have made plans to implement the Trigon system into their patient care. To date, 12 surgeries have been performed. Nvision, which was founded in 2013, is quickly becoming the largest medical device manufacturer in San Antonio with 17 FDA cleared devices across a range of orthopaedic specialties. In the last year, Nvision added seven products with FDA clearance to its portfolio with an additional two currently in FDA review.

"From the beginning, our goal with Nvision has been to engage in our community and provide innovative solutions for our families and neighbors and CHRISTUS Santa Rosa Health System has been a supporter of this mission," said Brian Kieser, Nvision founder. "By collaborating with hospitals like CHRISTUS Santa Rosa Hospital – Westover Hills and local surgeons like Dr. Farber, we are making great strides with bringing healthcare innovation to San Antonio, our home."

About Dr. Robert Farber
Dr. Robert Farber received his Doctorate of Podiatric Medicine with honors from Temple University School of Podiatric Medicine in Philadelphia. While enrolled, he served as the President of the Student Government. He was also inducted into the national podiatric honor and service societies.

Dr. Farber then completed his residency at Inova Fairfax Medical Campus in Fairfax, Virginia, where he served as Chief Podiatric Resident. While in residency, he performed more than 1,800 procedures from elective bunion and hammertoe surgery to complex rearfoot and ankle reconstruction. He also published multiple podiatric medical and surgical abstracts, resulting in a national award in forefoot surgery.

About Nvision Biomedical Technologies
Nvision is a San Antonio-based medical device and implant manufacturer focused on providing surgeons with implants paired with instrumentation and biologics that simplify and improve surgery procedures to help patients get back to their quality of life. Nvision is committed to developing and manufacturing thoughtfully designed products combined with exceptional service that keep the patient, surgeons, healthcare providers, and distribution partners in mind.

Nvision is aligned with surgeon thought leaders, key researchers, and development engineers from prestigious institutions to design, test, and bring to market the most innovative concepts. Find out more at http://www.nvisionbiomed.com

About CHRISTUS Santa Rosa Health System
Founded in 1869 by the Sisters of Charity of the Incarnate Word of Houston and San Antonio, CHRISTUS Santa Rosa is a Catholic, faith-based, nonprofit health and wellness ministry dedicated to extending the healing ministry of Jesus Christ and providing the highest quality medical care and services available. As one of the top health care organizations in South-Central Texas, CHRISTUS Santa Rosa has five hospital campuses. The Children's Hospital is located in downtown San Antonio. We also have hospitals located in the South Texas Medical Center, New Braunfels, San Marcos, Westover Hills, and a surgical hospital in Alamo Heights. CHRISTUS Santa Rosa Health System also owns a majority interest in CHRISTUS Santa Rosa Physicians Ambulatory Surgery Centers – San Antonio, LLC, a joint venture physician partnership, which is comprised of two outpatient surgery centers in San Antonio with facilities in Stone Oak and the Medical Center.

Additionally, CHRISTUS Santa Rosa Health System owns a majority interest in the CHRISTUS Santa Rosa Physicians Ambulatory Surgery Centers in New Braunfels and San Marcos, which are joint venture physician partnerships.

For additional information on CHRISTUS Santa Rosa, visit http://www.christussantarosa.org. Find us on Facebook at http://www.facebook.com/christussantarosa and follow us on Twitter at http://twitter.com/CSRHS.

Media Contact

BONNIE CAVER, Reputation Lighthouse, +1 (512) 832-8588, [email protected]

SOURCE Nvision Biomedical Technologies

Related Links

http://www.nvisionbiomed.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.